Sommaire

• • ·Programme

    Page :S87

    Résumé Résumé Plan Plan

• Editorial

  • ·Welcome to the 5^th Annual Meeting of the Diabetes & Cardiovascular Disease

    Page :S85

     

• Invited Speakers Presentations

  • ·ISP1: Incretin therapy and cardiovascular risk

    Page :S89

    N. Marx

    
  • ·ISP2: Non glycemic effects of DPP-4 inhibitors

    Page :S89

    A. Avogaro

    
  • ·ISP3: Myocardial Grafting and Diabetes

    Page :S89

    P. Menasché

    
  • ·ISP4: Markers of cardiovascular disease in the sleep apnea syndrome

    Page :S90

    S. Möhlenkamp

    
  • ·ISP5: Metabolic disorders in the sleep apnea syndrome

    Page :S90

    J. Wilding

    
  • ·ISP6: Silent myocardial ischemia in diabetic patients

    Page :S90

    E. Cosson

    
  • ·ISP7: Care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome

    Page :S90

    B. Vergès

    Résumé Résumé Plan Plan
  • ·ISP8: Targeting normoglycemia in dysglycaemia patients at high CV risks: what are the benefits and risks?”

    Page :S91

    L. Rydén

    
  • ·ISP9: Not all fat is bad in cardiovascular risk. Mechanistic considerations about visceral versus femoral adipose tissues

    Page :S91

    M. Lafontan

    
  • ·ISP10: A model for predicting cardiovascular risk in patients with type 2 diabetes mellitus based on the ADVANCE study

    Page :S91

    F. Travert

    Résumé Résumé Plan Plan
  • ·ISP11: What is behind the cardiovascular residual risk?

    Page :S92

    Paul Valensi

    
  • ·ISP12: Role of postprandial hyperglycemia and glycemic variability

    Page :S92

    A. Ceriello

    
  • ·ISP13: Advanced glycation endproducts in food and medicine

    Page :S92

    C.G. Schalkwijk

    
  • ·ISP14: Exercise, sympatho-vagal balance and postprandial glucose profile

    Page :S92

    D. Chapelot

    Résumé Résumé Plan Plan
  • ·ISP15: Functional and morphological changes in the arterial wall in diabetes and aging. Role of AGEs

    Page :S93

    N. Grossin

    
  • ·ISP16: Endothelial dysfunction in type 2 diabetes

    Page :S93

    A. Natali

    Résumé Résumé Plan Plan
  • ·ISP17: Microvascular rarefaction in diabetes and hypertension

    Page :S94

    B.I. Lévy

    
  • ·ISP18: Artery stiffness and remodelling in diabetes and renal failure

    Page :S94

    P. Boutouyrie

    
  • ·ISP19: Impaired glucose tolerance and cardiovascular risk

    Page :S94

    O. Schnell

    Résumé Résumé Plan Plan
  • ·ISP20: Should we still revascularize diabetic patients with coronary artery disease and how ?

    Page :S95

    O. Varenne

    
  • ·ISP21: Which antiaggregant strategy in diabetic patients with coronary artery disease?

    Page :S95

    M. Gilard

    
  • ·ISP22: Metabolic determinants of cerebrovascular disease in type 2 diabetes

    Page :S95

    N. Lalic

    Résumé Résumé Plan Plan
  • ·ISP23: Aspirin efficacy in diabetes

    Page :S96

    J.G. Dillinger, C. Bal dit Sollier, P. Henry, L. Drouet

    
  • ·ISP24: New oral anticoagulants

    Page :S96

    S. Apostolakis

    
  • ·ISP25: Early left ventricular dysfunction in diabetes

    Page :S96

    C.B. Giorda

    Résumé Résumé Plan Plan
  • ·ISP26: How molecular imaging may guide personalized cardiovascular risk assessment and care?

    Page :S97

    François Rouzet

    
  • ·ISP27: Omega 3 PUFA chain length: a key factor of their efficiency on cardiovascular risk factors in experimental metabolic syndrome

    Page :S97

    A. Grynberg

    Résumé Résumé

• Oral presentations

  • ·OP1: Risk predictors of cardio- and cerebrovascular hospital mortality in diabetic patients of the Munich Registries

    Page :S98

    P. Boenner, S. Bardutzky, E. Standl, M. Hummel, O. Schnell

    Résumé Résumé
  • ·OP2: Presence of albuminuria can determine eligible subjects for the screening of coronary artery disease in patients with diabetes mellitus

    Page :S98

    S. Sanghoon, K. Kwang-Joon, C. Iksung, C. Byoung-Wook, K. Young Jin, R. Yumie, Y. Woo-In, S. Chi-Young, H. Jong-Won, J. Yangsoo, C. Namsik, L. Sung-Kil, C. Hyuk-Jae

    Résumé Résumé
  • ·OP3: Oxidized LDL as residual lipid risk marker in type 2 diabetes

    Page :S98

    N. Rajkovic, M. Zamaklar, K. Lalic, N.M. Lalic, L. Popovic, D. Draskovic-Radojkovic, S. Singh, L. Stosic, A. Jotic, L. Lukic, T. Milicic

    Résumé Résumé Plan Plan
  • ·OP4: Metformin decreases plasma levels of fibulin-1, a novel marker of arterial matrix alterations in diabetes

    Page :S99

    L.M. Rasmussen, V. Skov, C. Cangemi, J. Gram, J.E. Henriksen

    Résumé Résumé
  • ·OP5: Low Cardiovascular (CV) Risk Hazard Ratio Observed with Linagliptin in Type 2 Diabetes: Further Insights from a Predefined CV Meta-Analysis

    Page :S99

    O.E. Johansen, D. Neubacher, M. von Eynatten, S. Patel, H.J. Woerle

    Résumé Résumé Plan Plan
  • ·OP6: Endothelium-independent vascular reactivity in high-fat diet-fed rats: role of vascular wall and perivascular adipose tissue oxidative stress

    Page :S100

    V. Achard, S. Tanguy, C. Sanchez, M. Verdier, Michel Grino

    Résumé Résumé
  • ·OP7: Chronic hyperglycemia induces GLP-1R resistance in terms of antioxidant and er stress response in HuVEC cells

    Page :S100

    G. Pujadas, L. La Sala, Antonio Ceriello

    Résumé Résumé Plan Plan
  • ·OP8: Early atherosclerosis in Familial Partial Lipodystrophy of the Dunnigan-type: Endothelial cell dysfunction induced by p.R482W lamin-A

    Page :S101

    G. Bidault, M. Garcia, M.C. Vantyghem, P.H. Ducluzeau, R. Morichon, K. Thiyagarajah, S. Moritz, J. Capeau, C. Vigouroux, V. Béréziat

    Résumé Résumé
  • ·OP9: Diet modulates endogenous thrombin generation, a biological estimate of thrombosis risk, independently of the metabolic status

    Page :S101

    C. Sanchez, M. Poggi, P.E. Morange, C. Defoort, J.C. Martin, S. Tanguy, A. Dutour, M. Grino, M.C. Alessi

    Résumé Résumé
  • ·OP10: Analysis of the relationship between the presence of metabolic syndrome with the level of oxidized LDL and impaired fibrinolysis in patients with patients with type 2 diabetes

    Page :S101

    S. Singh, K. Lalic, N. Rajkovic, L.J. Popovic, D. Draskovic, L.J. Stošic, M. Zamaklar

    Résumé Résumé Plan Plan
  • ·OP11: Metabolic and vascular determinants of increased left ventricular torsion in patients with type 2 diabetes mellitus

    Page :S102

    M. Kuehl, R. Steeds, J. Townend, A. Tahrani, K. Dubb, S. Hughes, T. Phan, M.J. Stevens

    Résumé Résumé
  • ·OP12: Association between retinopathy and early echographic markers of cardiomyopathy in type 2 diabetes

    Page :S102

    A. Decker-Bellaton, C. Bergerot, L. Ernande, L. Groisne, G. Derumeaux, P. Moulin

    Résumé Résumé
  • ·OP13: The effect of poly(ADP-ribose)polymerase inhibitors on diabetes-induced heart dysfunctions

    Page :S102

    T. Kuchmerovska, M. Guzyk, L. Yanitska, I. Pentek, K. Diakun

    Résumé Résumé Plan Plan

• Poster presentations

  • ·P 1: Do adiponectin levels explain the atherogenic properties of Hp 2-2 phenotype in type 2 diabetic patients?

    Page :S103

    J. Frand, A. Borislavsky, Z. Matas, M. Boaz, M. Shargorodsky

    Résumé Résumé
  • ·P 2: CRP as a possible predictor for peripheral arterial disease in patients with type 2 diabetes

    Page :S103

    Lj. Popovic, K. Lalic, D. Draskovic Radojkovic, N. Rajkovic, S. Singh, Lj. Stosic, S. Smrzlic, M. Zamaklar

    Résumé Résumé Plan Plan
  • ·P 3: Insulin sensitivity and related atherogenic conditions in ischemic stroke: comparison between type 2 diabetics and nondiabetics

    Page :S104

    T. Milicic, N.M. Lalic, A. Jotic, V.S. Kostic, N. Covickovic Sternic, K. Lalic, L. Lukic, M. Mijailovic, N. Rajkovic, M. Macesic, J.P. Seferovic Mitrovic, J. Stanarcic

    Résumé Résumé
  • ·P 4: Association of insulin sensitivity level and atherogenic lipid profile in mild cognitive impairment

    Page :S104

    M. Macesic, N.M. Lalic, V.S. Kostic, A. Jotic, E. Stefanova, K. Lalic, T. Milicic, Lj. Lukic, J. Seferovic-Mitrovic, J. Stanarcic

    Résumé Résumé
  • ·P 5: Value of the UKPDS risk score in the screening of asymptomatic type 2 diabetic patients for coronary stenoses and artery stiffness

    Page :S105

    Azzedine Belhadj-Mostefa, Daoud Roula, Paul Valensi

    Résumé Résumé
  • ·P 6: Markers of systemic inflammation and ApoAI-containing HDL subpopulations in women with and without diabetes

    Page :S105

    G.T. Russo, E.L. Romeo, A. Giandalia, A. Alibrandi, K.V. Horvath, A. Di Benedetto, D. Cucinotta, B. Asztalos

    Résumé Résumé
  • ·P 7: Does choice of antidiabetic and/or antihypertensive treatment influence progression of nephropathy in hypertensive type 2 diabetic patients?

    Page :S105

    S. Jelic

    Résumé Résumé Plan Plan
  • ·P 8: Peripheral insulin resistance influence the presence of hypertension in overweight type 2 diabetic patients

    Page :S106

    L. Lukic, N.M. Lalic, A. Jotic, N. Rajkovic, T. Milicic, M. Zamaklar, K. Lalic, J.P. Seferovic Mitrovic, M. Macesic, J. Stanarcic

    Résumé Résumé
  • ·P 9: Taurine protects against impairment of mitochondrial function and oxidative stress in the heart of rats with fructose-induced insulin resistance

    Page :S106

    N. Gorbenko, T. Zvyagina, O. Borikov, A. Shalamay, O. Ivanova

    Résumé Résumé Plan Plan
  • ·P 10: Enhancement of antioxidant defence against oxidative stress by timolol-treatment prevents age-/diabetes-related cardiac dysfunction via recovery of intracellular Ca2+ handling

    Page :S107

    B. Turan

    Résumé Résumé
  • ·P 11: Role of herbal extracts in the prevention of oxidative stress and modulation of atherogenic risk factors in experimentally-induced DM

    Page :S107

    M.A. El-Missiry, A.I. Othman

    Résumé Résumé Plan Plan
  • ·P 12: Chronic and oscillating high glucose induce, through oxidative stress, A “memory” effect for endoglin and NRF-2-downstream genes in endothelial cells

    Page :S108

    L. La Sala, G. Pujadas, A. Ceriello

    Résumé Résumé
  • ·P 13: Chemokine receptor antagonists influence on monocytes infiltration through endothelial cells monolayer studied by a real-time electrical impedance assay

    Page :S108

    D. Stan, V. Simion, A.M. Gan, M. Pirvulescu, E. Butoi, I. Manduteanu, M. Calin

    Résumé Résumé
  • ·P 14: Hypertriglyceridemic waist phenotype in type 2 diabetes: association with higher hs-CRP and lower antioxidative enzyme activity

    Page :S109

    D. Draskovic Radojkovic, K. Lalic, L. Popovic, N. Rajkovic, S. Singh, L. Stosic, M. Zamaklar

    Résumé Résumé
  • ·P 15: Low serum levels of L-Selectin as markers of silent myocardial ischemia and endothelial dysfunction in type 2 diabetic patients

    Page :S109

    E. Cosson, A. Sutton, M.T. Nguyen, I. Pham, N. Charnaux, P. Valensi

    Résumé Résumé
  • ·P 16: Role of short-term and advanced glycation end products in arterial stiffness in diabetes and prediabetes

    Page :S109

    M. Fysekidis, A. Rezki, R. Dina, E. Cosson, P. Valensi

    Résumé Résumé Plan Plan
  • ·P 17: Analysis of the relationship between parameters of total and abdominal obesity, levels of lipoproteins and occurrence of coronary heart disease in type 2 diabetes

    Page :S110

    L. Stosic, K. Lalic, N. Rajkovic, L. Popovic, D. Draskovic, S. Singh, S. Smrzlic, M. Zamaklar

    Résumé Résumé
  • ·P 18: The prevalence of multivessels coronary stenosis in patients with diabetes mellitus

    Page :S110

    G. Mankovsky, M. Sokolov

    Résumé Résumé
  • ·P 19: Obesity: Modeling the effect on human biomass and the impact on type 2 Diabetes

    Page :S111

    A. Boutayeb, M.E.N. Lamlili, W. Boutayeb

    Résumé Résumé
  • ·P 20: Coronary microvascular response to a coldpressor test and cardiac autonomic neuropathy in asymptomatic type 2 diabetic patients free of coronary stenoses

    Page :S111

    M.T. Nguyen, I. Pham, E. Cosson, A. Nitenberg, P. Valensi

    Résumé Résumé
  • ·P 21: Clinical and metabolic correlates of diastolic dysfunction in patients with type 2 diabetes

    Page :S111

    J.P. Seferovic Mitrovic, N.M. Lalic, P.M. Seferovic, A. Jotic, A.D. Ristic, M. Tešic, V. Giga, L. Lukic, T. Milicic, M. Macešic, J. Stanarcic

    Résumé Résumé Plan Plan
  • ·P 22: Omega-3 polyunsaturated fatty acids alleviates heart pump function in Type I diabetic cardiomyopathy

    Page :S112

    A. Zhukovska, A. Shysh, V. Dosenko, M. Kuzmenko, A. Moybenko

    Résumé Résumé
  • ·P 23: The possible contribution of thyroid hormones to insulin effect on beta adrenoceptor mediated cardiac responses in diabetic rats

    Page :S112

    E. Arioglu-Inan, I. Ozakca, G. Kayki-Mutlu, A. Sepici-Dincel, V.M. Altan

    Résumé Résumé Plan Plan
  • ·P 24: Non alcoholic fatty liver disease in type 2 diabetes patients

    Page :S113

    B. Idzior-Walus, A. Trojak, M.T. Małecki, M. Walus-Miarka, E. Wozniakiewicz

    
  • ·P 25: Effect of metformin on arterial properties, adiponectin, leptin and glucose homeostasis in patients with nonalcoholic fatty liver disease

    Page :S113

    A. Borislavsky, J. Frand, Z. Matas, M. Boaz, M. Shargorodsky

    Résumé Résumé
  • ·P 26: Metabolic effects of simvastatin and Omega-3 polyunsaturated fatty acids in type 2 diabetic patients with cardiovascular autonomic neuropathy

    Page :S113

    V.A. Serhiyenko, A.A. Serhiyenko, V.B. Segin, S.Y. Sandurska, A. Azmi

    Résumé Résumé Plan Plan
  • ·P 27: Inflammatory effects of resistin on human smooth muscle cells: up-regulation of fractalkine/CX3CR1 expression by TLR4 and Gi proteins pathways

    Page :S114

    A.M. Gan, E. Butoi, A. Manea, V. Simion, D. Stan, M.M. Parvulescu, M. Calin, I. Manduteanu, M. Simionescu

    Résumé Résumé
  • ·P 28: Some contributions to the evaluation of ethnomedical antidiabetic claims of African medicinal plants

    Page :S114

    A.C. Adebajo

    Résumé Résumé Plan Plan
  • ·P 29: Insulinotropic constituents and evaluation of ethnomedical claim of gongronema latifolium root and stem

    Page :S115

    A.C. Adebajo, M.D. Ayoola, S.A. Odediran, A.J. Aladesanmi, T.J. Schmidt, E.J. Verspohl

    Résumé Résumé
  • ·P 30: Cardiovascular risk factors in type 2 diabetes along 3 years of follow-up

    Page :S115

    F. Arrieta, M. Piñera, P. Nogales, R. Iglesias, E. Tutor, M. Salinero, J.C. Abanades, J.I. Botella, A. Calañas, P. Iglesias, J.A. Balsa, I. Zamarron, A. Rovira, C. Vazquez, group ESD2

    Résumé Résumé
  • ·P 31: Medication intensification strategies and outcomes in patients with type 2 diabetes (T2DM) who have A1C ≥ %7 on ≤ 2 oral anti-diabetes agents (OAD)

    Page :S115

    M. Korytkowski, M.S. Lombardero, M. Saul, M. Mori Brooks, T.J. Orchard, V.G. Magaji, J. Kanter, L. Siminerio

    Résumé Résumé Plan Plan